Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Graves Ophthalmopathy | 21 | 2023 | 117 | 10.070 |
Why?
|
Orbital Neoplasms | 20 | 2023 | 225 | 6.190 |
Why?
|
Eyelids | 18 | 2023 | 265 | 5.330 |
Why?
|
Orbit | 21 | 2023 | 426 | 4.920 |
Why?
|
Orbital Diseases | 12 | 2022 | 181 | 4.400 |
Why?
|
Eyelid Diseases | 14 | 2022 | 155 | 4.300 |
Why?
|
Eyelid Neoplasms | 9 | 2022 | 94 | 3.360 |
Why?
|
Oculomotor Muscles | 7 | 2023 | 371 | 2.920 |
Why?
|
Ophthalmologic Surgical Procedures | 11 | 2021 | 349 | 2.750 |
Why?
|
Dacryocystorhinostomy | 9 | 2018 | 72 | 2.680 |
Why?
|
Conjunctival Neoplasms | 6 | 2020 | 79 | 2.560 |
Why?
|
Exophthalmos | 5 | 2023 | 97 | 2.470 |
Why?
|
Nasolacrimal Duct | 10 | 2018 | 74 | 2.470 |
Why?
|
Lacrimal Apparatus | 7 | 2022 | 225 | 2.220 |
Why?
|
Conjunctiva | 8 | 2022 | 494 | 2.220 |
Why?
|
Blepharoplasty | 6 | 2023 | 50 | 1.910 |
Why?
|
Endoscopy | 18 | 2023 | 1785 | 1.860 |
Why?
|
Ectropion | 4 | 2020 | 26 | 1.830 |
Why?
|
Optic Nerve Diseases | 5 | 2021 | 327 | 1.830 |
Why?
|
Orbital Pseudotumor | 4 | 2016 | 42 | 1.720 |
Why?
|
Orbital Implants | 4 | 2021 | 21 | 1.580 |
Why?
|
Blepharoptosis | 7 | 2021 | 143 | 1.540 |
Why?
|
Ophthalmology | 13 | 2023 | 508 | 1.530 |
Why?
|
Lacrimal Apparatus Diseases | 5 | 2019 | 65 | 1.480 |
Why?
|
Eye Diseases | 3 | 2022 | 669 | 1.460 |
Why?
|
Eye Infections, Bacterial | 4 | 2017 | 235 | 1.440 |
Why?
|
Mucormycosis | 3 | 2022 | 97 | 1.430 |
Why?
|
Pemphigoid, Benign Mucous Membrane | 3 | 2023 | 123 | 1.420 |
Why?
|
Entropion | 3 | 2020 | 10 | 1.370 |
Why?
|
Visual Fields | 5 | 2020 | 1047 | 1.360 |
Why?
|
Orbital Fractures | 4 | 2020 | 110 | 1.320 |
Why?
|
Lacrimal Duct Obstruction | 5 | 2016 | 48 | 1.260 |
Why?
|
Intubation | 3 | 2019 | 141 | 1.190 |
Why?
|
Orbital Cellulitis | 4 | 2015 | 33 | 1.180 |
Why?
|
Dacryocystitis | 3 | 2017 | 70 | 1.090 |
Why?
|
Eyebrows | 2 | 2017 | 28 | 1.040 |
Why?
|
Neurilemmoma | 3 | 2020 | 547 | 1.030 |
Why?
|
Decompression, Surgical | 6 | 2023 | 594 | 1.010 |
Why?
|
Hemangioma, Cavernous | 4 | 2023 | 110 | 1.000 |
Why?
|
Eye Neoplasms | 3 | 2019 | 313 | 0.990 |
Why?
|
Sphenoid Bone | 4 | 2021 | 172 | 0.910 |
Why?
|
Sentinel Lymph Node Biopsy | 2 | 2020 | 709 | 0.900 |
Why?
|
Nasal Cavity | 3 | 2016 | 313 | 0.890 |
Why?
|
Mucorales | 2 | 2022 | 33 | 0.890 |
Why?
|
Diplopia | 6 | 2023 | 200 | 0.870 |
Why?
|
Vision Disorders | 3 | 2019 | 1058 | 0.860 |
Why?
|
Corneal Diseases | 3 | 2019 | 636 | 0.850 |
Why?
|
Anophthalmos | 2 | 2021 | 22 | 0.830 |
Why?
|
Vascular Malformations | 2 | 2020 | 454 | 0.810 |
Why?
|
Minocycline | 1 | 2022 | 163 | 0.800 |
Why?
|
Keratoacanthoma | 1 | 2021 | 33 | 0.780 |
Why?
|
Hyperpigmentation | 1 | 2022 | 112 | 0.780 |
Why?
|
Suture Techniques | 3 | 2014 | 798 | 0.750 |
Why?
|
Frail Elderly | 2 | 2016 | 693 | 0.750 |
Why?
|
Tomography, X-Ray Computed | 24 | 2021 | 20129 | 0.700 |
Why?
|
Imidazoles | 2 | 2017 | 1206 | 0.700 |
Why?
|
Ophthalmic Nerve | 1 | 2019 | 43 | 0.690 |
Why?
|
Humans | 150 | 2024 | 744343 | 0.690 |
Why?
|
Cysts | 4 | 2018 | 678 | 0.690 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2019 | 44 | 0.680 |
Why?
|
Biopsy | 11 | 2020 | 6756 | 0.650 |
Why?
|
Lymphatic Abnormalities | 1 | 2020 | 133 | 0.650 |
Why?
|
Technology Assessment, Biomedical | 5 | 2021 | 306 | 0.640 |
Why?
|
Eye Injuries | 4 | 2019 | 245 | 0.640 |
Why?
|
Factor XIIIa | 1 | 2017 | 10 | 0.630 |
Why?
|
Horner Syndrome | 1 | 2018 | 37 | 0.630 |
Why?
|
Eye Infections, Fungal | 2 | 2016 | 110 | 0.630 |
Why?
|
Eye, Artificial | 1 | 2017 | 18 | 0.620 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 2 | 2018 | 180 | 0.620 |
Why?
|
Blepharophimosis | 1 | 2017 | 22 | 0.620 |
Why?
|
Sarcoma, Myeloid | 1 | 2018 | 59 | 0.610 |
Why?
|
Nerve Transfer | 1 | 2019 | 120 | 0.610 |
Why?
|
Nevus | 1 | 2019 | 204 | 0.610 |
Why?
|
Dermoid Cyst | 1 | 2018 | 93 | 0.610 |
Why?
|
Ectodermal Dysplasia | 1 | 2018 | 106 | 0.600 |
Why?
|
Eye Hemorrhage | 1 | 2017 | 19 | 0.600 |
Why?
|
Retinal Vein Occlusion | 1 | 2018 | 137 | 0.600 |
Why?
|
Cranial Nerve Diseases | 1 | 2017 | 112 | 0.590 |
Why?
|
Skull Neoplasms | 1 | 2018 | 173 | 0.590 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 2017 | 109 | 0.590 |
Why?
|
Retrospective Studies | 48 | 2023 | 77449 | 0.580 |
Why?
|
Orbit Evisceration | 1 | 2016 | 8 | 0.580 |
Why?
|
Pyoderma Gangrenosum | 1 | 2017 | 76 | 0.570 |
Why?
|
Cicatrix | 3 | 2019 | 764 | 0.570 |
Why?
|
Port-Wine Stain | 1 | 2016 | 33 | 0.570 |
Why?
|
Fasciitis, Necrotizing | 1 | 2017 | 79 | 0.570 |
Why?
|
Choroid | 1 | 2018 | 322 | 0.570 |
Why?
|
Tomography, Optical Coherence | 3 | 2019 | 2657 | 0.560 |
Why?
|
Eye Foreign Bodies | 1 | 2017 | 55 | 0.560 |
Why?
|
Dermis | 1 | 2017 | 207 | 0.550 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2017 | 294 | 0.550 |
Why?
|
Maxillary Sinus | 2 | 2014 | 180 | 0.550 |
Why?
|
Surgical Sponges | 1 | 2016 | 46 | 0.550 |
Why?
|
Debridement | 3 | 2017 | 492 | 0.550 |
Why?
|
Middle Aged | 64 | 2023 | 213383 | 0.540 |
Why?
|
Sphenoid Sinus | 2 | 2018 | 99 | 0.540 |
Why?
|
Oximes | 1 | 2017 | 311 | 0.540 |
Why?
|
Erythema | 1 | 2017 | 257 | 0.540 |
Why?
|
Nerve Compression Syndromes | 1 | 2017 | 160 | 0.530 |
Why?
|
Antigens, CD34 | 1 | 2017 | 657 | 0.530 |
Why?
|
Mydriatics | 1 | 2015 | 68 | 0.520 |
Why?
|
Ethmoid Sinus | 1 | 2015 | 58 | 0.520 |
Why?
|
Sutures | 2 | 2014 | 299 | 0.520 |
Why?
|
Academies and Institutes | 7 | 2023 | 317 | 0.520 |
Why?
|
Oculomotor Nerve | 2 | 2019 | 74 | 0.510 |
Why?
|
Male | 77 | 2023 | 350118 | 0.510 |
Why?
|
Paranasal Sinus Diseases | 2 | 2021 | 116 | 0.510 |
Why?
|
Pyrimidinones | 1 | 2017 | 371 | 0.510 |
Why?
|
Glucocorticoids | 6 | 2022 | 2107 | 0.510 |
Why?
|
Fluorescein Angiography | 2 | 2018 | 940 | 0.500 |
Why?
|
Phenylephrine | 1 | 2015 | 301 | 0.500 |
Why?
|
Prosthesis Implantation | 3 | 2021 | 642 | 0.500 |
Why?
|
Contact Lenses | 1 | 2016 | 145 | 0.500 |
Why?
|
Rhabdomyosarcoma | 1 | 2017 | 382 | 0.490 |
Why?
|
Hernia | 1 | 2014 | 71 | 0.490 |
Why?
|
Skin Aging | 1 | 2015 | 127 | 0.490 |
Why?
|
Skin Transplantation | 2 | 2019 | 1074 | 0.480 |
Why?
|
Alopecia | 1 | 2018 | 382 | 0.480 |
Why?
|
Eyelashes | 1 | 2014 | 16 | 0.480 |
Why?
|
Skin Neoplasms | 4 | 2019 | 5686 | 0.480 |
Why?
|
Myxoma | 1 | 2014 | 130 | 0.470 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2018 | 604 | 0.470 |
Why?
|
Eye Infections, Viral | 1 | 2014 | 57 | 0.470 |
Why?
|
Ophthalmic Artery | 1 | 2014 | 60 | 0.470 |
Why?
|
Panophthalmitis | 1 | 2013 | 6 | 0.460 |
Why?
|
Edema | 2 | 2017 | 789 | 0.460 |
Why?
|
Nerve Regeneration | 1 | 2019 | 788 | 0.460 |
Why?
|
Facial Paralysis | 1 | 2017 | 338 | 0.460 |
Why?
|
Chalazion | 1 | 2013 | 13 | 0.460 |
Why?
|
Hyperglycemia | 1 | 2022 | 1373 | 0.450 |
Why?
|
Alendronate | 1 | 2014 | 171 | 0.450 |
Why?
|
Melanoma | 3 | 2017 | 5510 | 0.450 |
Why?
|
Aged, 80 and over | 24 | 2023 | 57776 | 0.450 |
Why?
|
Female | 75 | 2023 | 380194 | 0.450 |
Why?
|
Streptococcal Infections | 1 | 2017 | 638 | 0.430 |
Why?
|
Rhabdoid Tumor | 1 | 2014 | 212 | 0.430 |
Why?
|
Pyridones | 1 | 2017 | 712 | 0.430 |
Why?
|
Keratins | 2 | 2016 | 515 | 0.430 |
Why?
|
Aged | 45 | 2023 | 163280 | 0.420 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 2924 | 0.420 |
Why?
|
Terminology as Topic | 1 | 2019 | 1547 | 0.420 |
Why?
|
Carcinoma | 2 | 2015 | 2375 | 0.420 |
Why?
|
Fever | 3 | 2021 | 1616 | 0.420 |
Why?
|
Muscle Weakness | 1 | 2015 | 413 | 0.410 |
Why?
|
Emphysema | 1 | 2015 | 247 | 0.410 |
Why?
|
Surgical Flaps | 6 | 2022 | 1640 | 0.400 |
Why?
|
Cornea | 2 | 2019 | 1524 | 0.400 |
Why?
|
Keratosis, Actinic | 1 | 2012 | 74 | 0.400 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 687 | 0.380 |
Why?
|
Nose | 3 | 2023 | 509 | 0.360 |
Why?
|
Adipose Tissue | 3 | 2021 | 3279 | 0.360 |
Why?
|
Foreign Bodies | 1 | 2014 | 399 | 0.360 |
Why?
|
Neuroblastoma | 1 | 2018 | 1226 | 0.360 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2015 | 546 | 0.360 |
Why?
|
Cocaine-Related Disorders | 1 | 2013 | 460 | 0.350 |
Why?
|
Diphosphonates | 1 | 2014 | 623 | 0.350 |
Why?
|
Immunohistochemistry | 6 | 2019 | 11366 | 0.350 |
Why?
|
Escherichia coli Infections | 1 | 2013 | 532 | 0.340 |
Why?
|
Football | 1 | 2014 | 460 | 0.340 |
Why?
|
Herpesvirus 4, Human | 1 | 2014 | 1041 | 0.330 |
Why?
|
Blindness | 1 | 2013 | 617 | 0.330 |
Why?
|
Lymph Nodes | 1 | 2020 | 3474 | 0.330 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2021 | 4034 | 0.320 |
Why?
|
Visual Field Tests | 3 | 2019 | 383 | 0.320 |
Why?
|
Staphylococcal Infections | 1 | 2017 | 1400 | 0.320 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2019 | 1596 | 0.320 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2014 | 570 | 0.310 |
Why?
|
Craniopharyngioma | 2 | 2001 | 281 | 0.310 |
Why?
|
Receptors, Cell Surface | 1 | 2017 | 2866 | 0.310 |
Why?
|
Cocaine | 1 | 2013 | 1007 | 0.310 |
Why?
|
B-Lymphocytes | 3 | 2018 | 4665 | 0.310 |
Why?
|
Retina | 1 | 2018 | 2616 | 0.300 |
Why?
|
Geriatric Assessment | 1 | 2015 | 1372 | 0.300 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2017 | 2043 | 0.300 |
Why?
|
Self Report | 2 | 2016 | 3558 | 0.300 |
Why?
|
Adult | 40 | 2023 | 214055 | 0.300 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 1107 | 0.300 |
Why?
|
Eye Enucleation | 4 | 2021 | 128 | 0.290 |
Why?
|
Bone Density Conservation Agents | 1 | 2014 | 773 | 0.290 |
Why?
|
Dry Eye Syndromes | 2 | 2023 | 386 | 0.290 |
Why?
|
Antigens, CD | 1 | 2017 | 4026 | 0.290 |
Why?
|
Stents | 2 | 2019 | 3280 | 0.290 |
Why?
|
Hypesthesia | 2 | 2019 | 109 | 0.290 |
Why?
|
Anesthetics, Local | 1 | 2013 | 985 | 0.280 |
Why?
|
Magnetic Resonance Imaging | 19 | 2019 | 35421 | 0.270 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2014 | 2942 | 0.270 |
Why?
|
Treatment Outcome | 19 | 2023 | 63114 | 0.270 |
Why?
|
Psychometrics | 1 | 2015 | 3002 | 0.270 |
Why?
|
Germany | 3 | 2016 | 862 | 0.270 |
Why?
|
Molecular Targeted Therapy | 2 | 2016 | 2727 | 0.260 |
Why?
|
Bone Neoplasms | 1 | 2018 | 2529 | 0.260 |
Why?
|
Ultrasonography | 1 | 2019 | 5985 | 0.260 |
Why?
|
Diagnosis, Differential | 9 | 2021 | 12959 | 0.260 |
Why?
|
Surgery, Plastic | 1 | 2012 | 624 | 0.260 |
Why?
|
Skin Abnormalities | 2 | 2017 | 60 | 0.260 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1378 | 0.260 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 1519 | 0.260 |
Why?
|
Conjunctival Diseases | 2 | 2016 | 122 | 0.260 |
Why?
|
Disease Management | 1 | 2016 | 2459 | 0.260 |
Why?
|
Nasal Mucosa | 2 | 2018 | 373 | 0.250 |
Why?
|
Paranasal Sinuses | 2 | 2017 | 250 | 0.240 |
Why?
|
Quality of Life | 5 | 2022 | 12804 | 0.240 |
Why?
|
Quality Improvement | 1 | 2019 | 3749 | 0.230 |
Why?
|
Follow-Up Studies | 12 | 2019 | 39050 | 0.220 |
Why?
|
Epidermal Cyst | 2 | 2016 | 62 | 0.220 |
Why?
|
Receptors, Thyrotropin | 1 | 2022 | 45 | 0.220 |
Why?
|
Pituitary Neoplasms | 2 | 2001 | 1345 | 0.210 |
Why?
|
Dioxygenases | 1 | 2024 | 316 | 0.210 |
Why?
|
Materia Medica | 1 | 2021 | 12 | 0.200 |
Why?
|
Postoperative Complications | 5 | 2021 | 15295 | 0.200 |
Why?
|
Ecchymosis | 1 | 2021 | 32 | 0.200 |
Why?
|
Otolaryngology | 2 | 2020 | 645 | 0.200 |
Why?
|
Face | 3 | 2023 | 994 | 0.190 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5535 | 0.190 |
Why?
|
Salmonella enteritidis | 1 | 2000 | 17 | 0.190 |
Why?
|
Oxazolone | 1 | 2020 | 60 | 0.190 |
Why?
|
Systemic Vasculitis | 1 | 2020 | 37 | 0.180 |
Why?
|
Antineoplastic Agents | 4 | 2019 | 13695 | 0.180 |
Why?
|
Polyhydroxyethyl Methacrylate | 1 | 2019 | 31 | 0.180 |
Why?
|
Giant Cell Arteritis | 1 | 2024 | 292 | 0.180 |
Why?
|
Streptavidin | 1 | 1999 | 81 | 0.170 |
Why?
|
Tears | 2 | 2020 | 256 | 0.170 |
Why?
|
Optic Nerve Injuries | 1 | 2020 | 150 | 0.170 |
Why?
|
Scleral Buckling | 1 | 2019 | 84 | 0.170 |
Why?
|
Maxillary Fractures | 1 | 2019 | 20 | 0.170 |
Why?
|
Prevalence | 1 | 2016 | 15226 | 0.170 |
Why?
|
Zygomatic Fractures | 1 | 2019 | 37 | 0.170 |
Why?
|
Sclerotherapy | 1 | 2020 | 175 | 0.170 |
Why?
|
Vitamin K | 1 | 2021 | 295 | 0.170 |
Why?
|
Rupture | 4 | 2014 | 433 | 0.170 |
Why?
|
Food Contamination | 1 | 2000 | 188 | 0.170 |
Why?
|
Strabismus | 1 | 2023 | 287 | 0.170 |
Why?
|
Salmonella Infections | 1 | 2000 | 173 | 0.170 |
Why?
|
Hemianopsia | 1 | 2000 | 122 | 0.160 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 221 | 0.160 |
Why?
|
Biotin | 1 | 1999 | 254 | 0.160 |
Why?
|
Facial Neoplasms | 1 | 2019 | 121 | 0.160 |
Why?
|
Palate, Hard | 1 | 2018 | 57 | 0.160 |
Why?
|
Adolescent | 14 | 2023 | 85781 | 0.160 |
Why?
|
Preoperative Period | 2 | 2017 | 549 | 0.150 |
Why?
|
Plant Extracts | 1 | 2021 | 471 | 0.150 |
Why?
|
Penicillin G | 1 | 2017 | 42 | 0.150 |
Why?
|
Drug Therapy, Combination | 3 | 2017 | 6489 | 0.150 |
Why?
|
Blinking | 2 | 2017 | 138 | 0.150 |
Why?
|
Lacerations | 1 | 2019 | 144 | 0.150 |
Why?
|
Sampling Studies | 1 | 2019 | 623 | 0.150 |
Why?
|
Nuclear Medicine | 1 | 2020 | 233 | 0.150 |
Why?
|
Fundus Oculi | 1 | 2018 | 473 | 0.150 |
Why?
|
Combined Modality Therapy | 3 | 2017 | 8642 | 0.150 |
Why?
|
Corneal Ulcer | 2 | 2017 | 169 | 0.150 |
Why?
|
Cadaver | 3 | 2019 | 1337 | 0.150 |
Why?
|
Visual Acuity | 6 | 2016 | 2530 | 0.150 |
Why?
|
Submandibular Gland | 1 | 2017 | 86 | 0.140 |
Why?
|
Streptococcus | 1 | 2017 | 197 | 0.140 |
Why?
|
Cautery | 1 | 2017 | 72 | 0.140 |
Why?
|
Optic Disk | 1 | 2020 | 400 | 0.140 |
Why?
|
Anti-Bacterial Agents | 4 | 2022 | 7181 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 9239 | 0.140 |
Why?
|
Exanthema | 1 | 2021 | 501 | 0.140 |
Why?
|
Silicone Elastomers | 1 | 2016 | 84 | 0.140 |
Why?
|
Pigmentation | 1 | 2016 | 148 | 0.140 |
Why?
|
Panuveitis | 1 | 2016 | 32 | 0.140 |
Why?
|
Infant | 7 | 2023 | 35136 | 0.140 |
Why?
|
Eye Pain | 2 | 2013 | 47 | 0.140 |
Why?
|
Carotid-Cavernous Sinus Fistula | 1 | 2016 | 40 | 0.140 |
Why?
|
Melanosis | 1 | 2016 | 78 | 0.130 |
Why?
|
Hospitals, Special | 1 | 2016 | 101 | 0.130 |
Why?
|
Gels | 1 | 2017 | 427 | 0.130 |
Why?
|
Models, Anatomic | 1 | 2019 | 691 | 0.130 |
Why?
|
Immunoglobulin G | 3 | 2023 | 4560 | 0.130 |
Why?
|
Hair Diseases | 1 | 2016 | 74 | 0.130 |
Why?
|
Histiocytes | 1 | 2015 | 103 | 0.130 |
Why?
|
Antibodies, Blocking | 1 | 2016 | 253 | 0.130 |
Why?
|
Lymphangiogenesis | 1 | 2016 | 172 | 0.130 |
Why?
|
Fusobacterium necrophorum | 1 | 2014 | 14 | 0.130 |
Why?
|
Cavernous Sinus Thrombosis | 1 | 2014 | 14 | 0.130 |
Why?
|
Silicones | 1 | 2016 | 250 | 0.130 |
Why?
|
Frontal Lobe | 1 | 2001 | 1406 | 0.130 |
Why?
|
Lemierre Syndrome | 1 | 2014 | 14 | 0.130 |
Why?
|
Neovascularization, Pathologic | 2 | 2016 | 2635 | 0.130 |
Why?
|
Eye Injuries, Penetrating | 3 | 1994 | 115 | 0.120 |
Why?
|
Consensus | 2 | 2020 | 2959 | 0.120 |
Why?
|
Antifungal Agents | 2 | 2016 | 730 | 0.120 |
Why?
|
Societies, Medical | 2 | 2019 | 3743 | 0.120 |
Why?
|
Retinal Cone Photoreceptor Cells | 1 | 2015 | 177 | 0.120 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2018 | 547 | 0.120 |
Why?
|
Glass | 1 | 2014 | 114 | 0.120 |
Why?
|
Young Adult | 7 | 2018 | 56430 | 0.120 |
Why?
|
Lymph Node Excision | 1 | 2020 | 1261 | 0.120 |
Why?
|
Bioartificial Organs | 1 | 2014 | 49 | 0.120 |
Why?
|
Translating | 1 | 2015 | 144 | 0.120 |
Why?
|
Remission, Spontaneous | 1 | 2014 | 382 | 0.120 |
Why?
|
Hair Follicle | 1 | 2016 | 209 | 0.120 |
Why?
|
Parotid Gland | 1 | 2014 | 168 | 0.120 |
Why?
|
Massachusetts | 2 | 2017 | 8663 | 0.120 |
Why?
|
Documentation | 1 | 2020 | 871 | 0.120 |
Why?
|
Vancomycin | 1 | 2017 | 501 | 0.120 |
Why?
|
False Negative Reactions | 1 | 2015 | 588 | 0.120 |
Why?
|
Prostaglandins, Synthetic | 1 | 2013 | 21 | 0.120 |
Why?
|
Leiomyosarcoma | 1 | 2017 | 477 | 0.110 |
Why?
|
Communicable Diseases | 1 | 2022 | 880 | 0.110 |
Why?
|
Aspergillosis | 1 | 2015 | 235 | 0.110 |
Why?
|
Microscopy, Confocal | 1 | 2019 | 1970 | 0.110 |
Why?
|
Eye Burns | 1 | 2014 | 103 | 0.110 |
Why?
|
Viscosupplements | 1 | 2013 | 23 | 0.110 |
Why?
|
Granuloma, Foreign-Body | 1 | 2013 | 45 | 0.110 |
Why?
|
Burns, Chemical | 1 | 2014 | 159 | 0.110 |
Why?
|
Sirolimus | 1 | 2020 | 1564 | 0.110 |
Why?
|
Endoscopes | 1 | 2013 | 175 | 0.110 |
Why?
|
Carcinoma, Lobular | 1 | 2017 | 484 | 0.110 |
Why?
|
Rupture, Spontaneous | 1 | 2013 | 354 | 0.110 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1799 | 0.110 |
Why?
|
United States | 9 | 2021 | 69872 | 0.110 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2019 | 1184 | 0.100 |
Why?
|
Azithromycin | 1 | 2013 | 196 | 0.100 |
Why?
|
Administration, Intranasal | 1 | 2013 | 446 | 0.100 |
Why?
|
Antibodies, Monoclonal | 2 | 2022 | 9274 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 2 | 2021 | 1855 | 0.100 |
Why?
|
Ophthalmoplegia | 1 | 2013 | 166 | 0.100 |
Why?
|
Imaging, Three-Dimensional | 3 | 2017 | 4042 | 0.100 |
Why?
|
Child | 8 | 2020 | 77709 | 0.100 |
Why?
|
Nasopharyngeal Diseases | 1 | 2011 | 25 | 0.100 |
Why?
|
Meningeal Neoplasms | 1 | 2020 | 1241 | 0.100 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2014 | 659 | 0.100 |
Why?
|
Uveitis | 1 | 2015 | 375 | 0.100 |
Why?
|
Reproducibility of Results | 3 | 2023 | 19905 | 0.100 |
Why?
|
Fluoroquinolones | 1 | 2013 | 310 | 0.100 |
Why?
|
Graft vs Host Disease | 1 | 2023 | 2957 | 0.100 |
Why?
|
Botulinum Toxins | 1 | 2013 | 191 | 0.100 |
Why?
|
Hemangioma | 1 | 2016 | 738 | 0.100 |
Why?
|
Abscess | 2 | 2014 | 607 | 0.090 |
Why?
|
Mycoses | 1 | 2014 | 376 | 0.090 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 5221 | 0.090 |
Why?
|
Paraproteinemias | 1 | 2013 | 246 | 0.090 |
Why?
|
Ultraviolet Rays | 1 | 2015 | 1060 | 0.090 |
Why?
|
Inflammation | 4 | 2022 | 10638 | 0.090 |
Why?
|
Muscle Contraction | 1 | 2015 | 1240 | 0.090 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11031 | 0.090 |
Why?
|
In Situ Hybridization | 1 | 2014 | 1950 | 0.090 |
Why?
|
Lymphocytes | 1 | 2018 | 2617 | 0.090 |
Why?
|
Mohs Surgery | 1 | 2012 | 197 | 0.090 |
Why?
|
Breast Neoplasms | 2 | 2017 | 20822 | 0.090 |
Why?
|
Radiography | 3 | 2015 | 7023 | 0.090 |
Why?
|
Infarction | 1 | 2011 | 244 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2021 | 1587 | 0.090 |
Why?
|
Molecular Biology | 1 | 2013 | 596 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2020 | 3508 | 0.080 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2016 | 1676 | 0.080 |
Why?
|
Gene Rearrangement | 1 | 2014 | 1179 | 0.080 |
Why?
|
Postoperative Care | 1 | 2015 | 1486 | 0.080 |
Why?
|
Uterine Neoplasms | 1 | 2017 | 1513 | 0.080 |
Why?
|
Thyroid Neoplasms | 1 | 2020 | 2282 | 0.070 |
Why?
|
Lung Neoplasms | 2 | 2009 | 13102 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2017 | 1790 | 0.070 |
Why?
|
Sinusitis | 1 | 2015 | 923 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3703 | 0.070 |
Why?
|
Viral Load | 1 | 2014 | 3299 | 0.060 |
Why?
|
Graft Survival | 1 | 2015 | 3737 | 0.060 |
Why?
|
Meige Syndrome | 1 | 2004 | 12 | 0.060 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6171 | 0.060 |
Why?
|
Fatal Outcome | 1 | 2009 | 1850 | 0.060 |
Why?
|
Wound Healing | 1 | 2015 | 2785 | 0.060 |
Why?
|
Blepharospasm | 1 | 2004 | 30 | 0.060 |
Why?
|
Cyanobacteria | 1 | 2004 | 49 | 0.060 |
Why?
|
Amyloidosis | 1 | 2011 | 795 | 0.060 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2133 | 0.060 |
Why?
|
Recurrence | 1 | 2015 | 8340 | 0.060 |
Why?
|
Immunotherapy | 1 | 2019 | 4445 | 0.060 |
Why?
|
Infant, Newborn | 3 | 2018 | 25625 | 0.060 |
Why?
|
Glaucoma | 1 | 2013 | 1159 | 0.060 |
Why?
|
Antibodies, Viral | 1 | 2014 | 3176 | 0.060 |
Why?
|
Disease Progression | 1 | 2019 | 13284 | 0.060 |
Why?
|
Health Status | 1 | 2016 | 4034 | 0.050 |
Why?
|
Anemia, Sickle Cell | 1 | 2011 | 1018 | 0.050 |
Why?
|
Neuromuscular Agents | 1 | 2004 | 134 | 0.050 |
Why?
|
Radiotherapy | 1 | 2009 | 1533 | 0.050 |
Why?
|
Dermatology | 1 | 2012 | 872 | 0.050 |
Why?
|
Meibomian Glands | 1 | 2022 | 85 | 0.050 |
Why?
|
Health Surveys | 1 | 2012 | 4037 | 0.050 |
Why?
|
Philadelphia | 2 | 1992 | 266 | 0.050 |
Why?
|
Survival Rate | 1 | 2016 | 12788 | 0.050 |
Why?
|
Eye Evisceration | 1 | 2021 | 23 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18370 | 0.050 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2015 | 1813 | 0.050 |
Why?
|
Neoplasm Seeding | 1 | 2001 | 87 | 0.050 |
Why?
|
Cyclin A | 1 | 2001 | 60 | 0.050 |
Why?
|
Iopamidol | 1 | 2002 | 191 | 0.050 |
Why?
|
Botulinum Toxins, Type A | 1 | 2004 | 213 | 0.050 |
Why?
|
Prognosis | 2 | 2020 | 29063 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2001 | 8863 | 0.050 |
Why?
|
Immunoglobulin A | 1 | 2023 | 992 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14722 | 0.040 |
Why?
|
Prospective Studies | 3 | 2020 | 53288 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2002 | 675 | 0.040 |
Why?
|
Referral and Consultation | 1 | 2012 | 3528 | 0.040 |
Why?
|
Time Factors | 3 | 2016 | 40075 | 0.040 |
Why?
|
Salivary Glands | 1 | 2020 | 229 | 0.040 |
Why?
|
Eggs | 1 | 2000 | 184 | 0.040 |
Why?
|
Bioengineering | 1 | 2019 | 99 | 0.040 |
Why?
|
Hydrolysis | 1 | 2019 | 682 | 0.040 |
Why?
|
Scalp | 1 | 2021 | 380 | 0.040 |
Why?
|
Echo-Planar Imaging | 1 | 2002 | 659 | 0.040 |
Why?
|
S100 Proteins | 1 | 2018 | 259 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10180 | 0.040 |
Why?
|
Vimentin | 1 | 2018 | 261 | 0.040 |
Why?
|
Aneuploidy | 1 | 2001 | 530 | 0.040 |
Why?
|
Thermodynamics | 1 | 1999 | 596 | 0.040 |
Why?
|
Fluoroscopy | 1 | 2002 | 924 | 0.040 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2019 | 118 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 23338 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11524 | 0.040 |
Why?
|
Benchmarking | 1 | 2023 | 1042 | 0.040 |
Why?
|
Iodine Radioisotopes | 1 | 2020 | 1032 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2017 | 4851 | 0.040 |
Why?
|
Drainage | 2 | 2014 | 1142 | 0.040 |
Why?
|
Scleritis | 1 | 2017 | 100 | 0.030 |
Why?
|
Aging | 1 | 2015 | 8664 | 0.030 |
Why?
|
Delphi Technique | 1 | 2019 | 778 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1999 | 1723 | 0.030 |
Why?
|
Craniotomy | 1 | 2000 | 729 | 0.030 |
Why?
|
Retinal Detachment | 1 | 2019 | 411 | 0.030 |
Why?
|
Head | 1 | 2021 | 880 | 0.030 |
Why?
|
Aspergillus | 1 | 2015 | 85 | 0.030 |
Why?
|
Nasal Septum | 1 | 2016 | 127 | 0.030 |
Why?
|
Papillomaviridae | 1 | 2021 | 1119 | 0.030 |
Why?
|
Parotitis | 1 | 2014 | 29 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 2001 | 1602 | 0.030 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2016 | 772 | 0.030 |
Why?
|
Crystallography, X-Ray | 1 | 1999 | 2011 | 0.030 |
Why?
|
Hyperbaric Oxygenation | 1 | 2015 | 163 | 0.030 |
Why?
|
Optic Nerve | 1 | 2017 | 554 | 0.030 |
Why?
|
Travel | 1 | 2000 | 788 | 0.030 |
Why?
|
Cloprostenol | 1 | 2013 | 22 | 0.030 |
Why?
|
Child, Preschool | 5 | 2016 | 41006 | 0.030 |
Why?
|
Prostaglandins F, Synthetic | 1 | 2013 | 32 | 0.030 |
Why?
|
Melanocytes | 1 | 2016 | 515 | 0.030 |
Why?
|
Meningitis | 1 | 2014 | 216 | 0.030 |
Why?
|
Pharyngitis | 1 | 2014 | 215 | 0.030 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2016 | 664 | 0.030 |
Why?
|
Cohort Studies | 1 | 2015 | 40561 | 0.030 |
Why?
|
Postoperative Period | 1 | 2017 | 1842 | 0.030 |
Why?
|
Polymers | 1 | 2019 | 1621 | 0.030 |
Why?
|
Lymphatic Vessels | 1 | 2016 | 353 | 0.030 |
Why?
|
Tumor Burden | 1 | 2017 | 1915 | 0.030 |
Why?
|
Ketone Bodies | 1 | 1991 | 82 | 0.030 |
Why?
|
Prednisone | 1 | 2016 | 1574 | 0.020 |
Why?
|
Clavulanic Acid | 1 | 2010 | 19 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2014 | 1588 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2004 | 3848 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2000 | 1772 | 0.020 |
Why?
|
Cerebral Angiography | 1 | 2016 | 1285 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2016 | 21746 | 0.020 |
Why?
|
Pneumonia | 1 | 2002 | 2133 | 0.020 |
Why?
|
Amides | 1 | 2013 | 459 | 0.020 |
Why?
|
Carotid Arteries | 1 | 2014 | 952 | 0.020 |
Why?
|
Prednisolone | 1 | 2011 | 334 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 1991 | 402 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3278 | 0.020 |
Why?
|
Subcutaneous Fat | 1 | 2013 | 391 | 0.020 |
Why?
|
Positron-Emission Tomography | 2 | 2017 | 6234 | 0.020 |
Why?
|
Ocular Motility Disorders | 1 | 2011 | 135 | 0.020 |
Why?
|
Amoxicillin | 1 | 2010 | 170 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2001 | 1912 | 0.020 |
Why?
|
Brachytherapy | 1 | 2017 | 1248 | 0.020 |
Why?
|
Growth Hormone | 1 | 1991 | 705 | 0.020 |
Why?
|
Contrast Media | 1 | 2002 | 5300 | 0.020 |
Why?
|
Reoperation | 1 | 2018 | 4201 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2002 | 8949 | 0.020 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2010 | 341 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25043 | 0.020 |
Why?
|
Demography | 1 | 1992 | 1656 | 0.020 |
Why?
|
Mutation | 2 | 2024 | 29786 | 0.020 |
Why?
|
DNA | 1 | 2001 | 7301 | 0.020 |
Why?
|
Proteomics | 1 | 2020 | 3638 | 0.020 |
Why?
|
Protein Binding | 1 | 1999 | 9386 | 0.020 |
Why?
|
Embolization, Therapeutic | 1 | 2016 | 1392 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2024 | 9648 | 0.020 |
Why?
|
Seasons | 1 | 1992 | 1493 | 0.020 |
Why?
|
Wounds, Nonpenetrating | 1 | 1992 | 794 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2011 | 2274 | 0.020 |
Why?
|
Smoking | 1 | 2023 | 8987 | 0.020 |
Why?
|
Hypothalamus | 1 | 1991 | 1063 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8324 | 0.020 |
Why?
|
Risk Factors | 5 | 2015 | 72290 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2001 | 8428 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15540 | 0.020 |
Why?
|
Pain | 1 | 2019 | 4986 | 0.020 |
Why?
|
Muscle Relaxation | 1 | 2004 | 142 | 0.020 |
Why?
|
Functional Laterality | 1 | 2011 | 2290 | 0.010 |
Why?
|
Software | 1 | 2017 | 4443 | 0.010 |
Why?
|
Diet | 1 | 2000 | 7939 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2001 | 6773 | 0.010 |
Why?
|
DNA Fingerprinting | 1 | 2001 | 112 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18029 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2016 | 13033 | 0.010 |
Why?
|
Glucose | 1 | 1991 | 4397 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12245 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2004 | 2029 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 2002 | 2480 | 0.010 |
Why?
|
Animals | 3 | 2020 | 168757 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81183 | 0.010 |
Why?
|
Swine | 1 | 2002 | 5917 | 0.010 |
Why?
|
Nicotinic Acids | 1 | 1991 | 31 | 0.010 |
Why?
|
Hydroxybutyrates | 1 | 1991 | 82 | 0.010 |
Why?
|
Oleic Acids | 1 | 1991 | 70 | 0.010 |
Why?
|
Injections, Intraventricular | 1 | 1991 | 230 | 0.010 |
Why?
|
Image Enhancement | 1 | 2002 | 2921 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2004 | 12026 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2001 | 15076 | 0.000 |
Why?
|
Macaca mulatta | 1 | 1991 | 2375 | 0.000 |
Why?
|
Hydrocortisone | 1 | 1991 | 1826 | 0.000 |
Why?
|
Insulin | 1 | 1991 | 6580 | 0.000 |
Why?
|